Medical News

RSS

Insurance exchange 'navigators,' new payment models claim roles in health law implementation

The Washington Post reports on the challenges involved in fielding a team of health exchange navigators to help people work through their choices and the process. Meanwhile, MedPage Today reports on comments made by Health and Human Services Secretary Kathleen Sebelius regarding the "obligation" providers have to try new payment models.

5 Feb 2013

Thoratec fourth quarter revenues increase 17% to $128.5 million

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2012.

5 Feb 2013

Patients with preinfarction angina have smaller heart attacks, improved cardiac function

Patients who experience chest pain in the 24 hours preceding a heart attack, also called preinfarction angina, have smaller heart attacks and improved cardiac function in the contemporary cardiac stenting era, researchers found in a study published Jan. 22 in Circulation: Cardiovascular Interventions.

5 Feb 2013

Acceleron commences dalantercept phase 2 study in metastatic renal cell carcinoma

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, announced the initiation of a phase 2 study of dalantercept, a novel angiogenesis inhibitor that targets the activin receptor-like kinase 1 (ALK1) pathway.

5 Feb 2013

Survivors of CNS cancer in childhood are at increased risk for disturbance in body image

Survivors of cancer of the central nervous system (CNS) in childhood are at heightened risk for disturbance in body image and self-image in relation to sports or other physical activities, according to a nationwide study from Karolinska Institutet in Sweden published in the Journal of Neuro-Oncology.

5 Feb 2013

U.S. should issue formal ban on using vaccination campaigns as cover for intelligence operations

In an opinion piece in Bloomberg Businessweek's "Small World" blog, Charles Kenny, a fellow at the Center for Global Development and the New America Foundation, examines the effects of "a fake polio vaccination drive organized by the CIA in an effort to collect DNA from [Osama] bin Laden's family" on polio immunization efforts in Pakistan.

5 Feb 2013

FDA approves Perrigo’s NDA for testosterone gel 1%

Perrigo Company announced that it has received U.S. Food and Drug Administration approval for its New Drug Application (NDA) for testosterone gel 1%.

5 Feb 2013

Mesa Laboratories third quarter revenues increase 18% to $11,361,000

Mesa Laboratories, Inc. today reported an 18 percent increase in revenues for the third quarter ended December 31, 2012.

5 Feb 2013

Fluke Biomedical debuts new VT305 Gas Flow Analyzer

Fluke Biomedical, a global provider of medical device test and safety equipment, announced today the debut of its new VT305 Gas Flow Analyzer. Designed for the highly mobile biomed or service engineer, the small lightweight VT305 is simple to use, provides quick results and is engineered for efficiency.

5 Feb 2013

Previously poorly investigated signalling pathway crucial for proliferation of prostate cancer cells

A previously poorly investigated signalling pathway is crucial for the growth and proliferation of prostate cancer cells. An international research team discovered this when studying the enzyme "soluble adenylyl cyclase" that produces the second messenger molecule cAMP.

5 Feb 2013

Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer

Acceleron Pharma, a biopharmaceutical company developing protein therapeutics for cancer and orphan disease, today announced that the Gynecologic Oncology Group (GOG) initiated a phase 2 study of dalantercept in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer.

5 Feb 2013

Researchers pinpoint how vitamin D3 and omega-3 may boost immunity to help fight Alzheimer's

A team of academic researchers has pinpointed how vitamin D3 and omega-3 fatty acids may enhance the immune system's ability to clear the brain of amyloid plaques, one of the hallmarks of Alzheimer's disease.

5 Feb 2013

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex, Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine.

5 Feb 2013

Stanmore receives FDA clearance for Sculptor Robotic Guidance Arm

Stanmore Implants, specialists in the design and manufacture of patient specific and modular orthopaedic implants, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Sculptor Robotic Guidance Arm for precision implant placement in unicompartmental knee surgery, also known as partial knee resurfacing.

5 Feb 2013

Viewpoints: Sen. Hatch's prescription for safeguarding entitlements; Medicare crackdown on CVS drug program; JFK's mental health vision failing

American families are used to working with dollar amounts starting with hundreds and thousands. But the fiscal situation of our country requires us to act in terms of billions and trillions. ... Unfortunately, waiting until the last minute to stop a crisis has become standard operating procedure in Washington. But that isn't how we should be tackling our debt or safeguarding Medicare and Medicaid.

5 Feb 2013

Viral conjunctivitis: potential new treatment

Viral conjunctivitis is a highly contagious infection, often causing major ophthalmic epidemics. There is no approved acute treatment currently approved by the FDA for viral conjunctivitis. A safe broad-spectrum antiviral agent is needed to treat this unmet medical need.

5 Feb 2013

Medical News

Insurance exchange 'navigators,' new payment models claim roles in health law implementation

Thoratec fourth quarter revenues increase 17% to $128.5 million

Patients with preinfarction angina have smaller heart attacks, improved cardiac function

Acceleron commences dalantercept phase 2 study in metastatic renal cell carcinoma

Survivors of CNS cancer in childhood are at increased risk for disturbance in body image

U.S. should issue formal ban on using vaccination campaigns as cover for intelligence operations

FDA approves Perrigo’s NDA for testosterone gel 1%

Mesa Laboratories third quarter revenues increase 18% to $11,361,000

Fluke Biomedical debuts new VT305 Gas Flow Analyzer

Previously poorly investigated signalling pathway crucial for proliferation of prostate cancer cells

Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer

Researchers pinpoint how vitamin D3 and omega-3 may boost immunity to help fight Alzheimer's

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Stanmore receives FDA clearance for Sculptor Robotic Guidance Arm

Viewpoints: Sen. Hatch's prescription for safeguarding entitlements; Medicare crackdown on CVS drug program; JFK's mental health vision failing

Viral conjunctivitis: potential new treatment

Injection-free vaccination technique shows promise

CT cancer risk small compared with underlying morbidity

Mental health risk increased in problem gamblers

UK cosmetic procedures standards announced

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News